OXFORD IMMUNOTEC GLOBAL PLC 2,500,000 Ordinary Shares Underwriting AgreementOxford Immunotec Global PLC • August 18th, 2017 • In vitro & in vivo diagnostic substances • New York
Oxford Immunotec Global PLC, a public limited company incorporated under the laws of England and Wales (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), an aggregate of 2,500,000 ordinary shares, £0.006705 nominal value per share, of the Company (the “Underwritten Shares”). In addition, the Company proposes to issue and sell, at the option of the Underwriters, up to an additional 375,000 ordinary shares of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The ordinary shares of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Ordinary Shares.” To the extent there are no additional Underwriters listed on Schedule I other than you, the terms Representative and Underwriters shall, mutatis mutandis, be deemed to refer to you.
